Table 3 Breast cancer risk assessment tools.
Risk Factor, Reference | NCI model 111 , 112 | Claus model 113 | Tyrer-Cuzick model 65 , 79 , 114 , 115 | BRCAPRO 67 , 73 | BOADICEA 66 , 71 , 72 | Tice 116 | Darabi 117 | Eriksson 118 |
---|---|---|---|---|---|---|---|---|
Abbreviations: NCI: National Cancer Institute; BOADICEA: Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm. | ||||||||
Age | + | + | + | + | + | + | + | + |
Age at menarche | + | + | + | |||||
Age at menopause | + | + | ||||||
Body mass index | + | + | + | |||||
Age at first birth | + | + | + | |||||
Mammographic density | + | + | + | + | ||||
Suspicious mammographic findings | + | |||||||
History of breast biopsies | + | + | + | + | ||||
History of premalignant lesions | + | + | + | |||||
Hormone replacement therapy | + | + | ||||||
Family history of breast cancer | + | + | + | + | + | + | + | |
Family history of ovarian cancer | + | + | + | |||||
Family history of prostate cancer | + | |||||||
Family history of pancreatic cancer | + | |||||||
Contralateral breast cancer | + | + | + | |||||
Histology of breast cancer | + | + | ||||||
BRCA1/2 mutation | + | + | + | + | ||||
Low penetrant genetic variants | (+) | + | ||||||
Ethnicity/Ashkenazi Jewish ancestry | + | + | + | + | + | + | ||
Mastectomy | + | |||||||
Oophorectomy | + |